Savara Inc — Director's Dealing 2014

Oct 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Mast Therapeutics, Inc. (MSTX)
CIK: 0001160308
Period of Report: 2014-10-01

Reporting Person: Parsley Edwin L. (Chief Medical Officer & SVP)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-01	Employee Stock Option (Right to Buy)	$0.59	A	600000	Acquired	2024-10-01	Common Stock (600000)	Direct

Footnotes

F1: This option vests and becomes exercisable as to 1/4th of the total number of shares subject to this option on October 1, 2015 and as to 1/48th of the total number of shares subject to this option monthly thereafter for the 36 months following October 2015, subject to the reporting person's continued service with the issuer.